Cormorant Asset Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-500,000
| Closed | -$10.1M | – | 78 |
|
|
2017
Q1 | $10.1M | Buy |
500,000
+19,499
| +4% | +$392K | 1.46% | 24 |
|
|
2016
Q4 | $7.49M | Hold |
480,501
| – | – | 1.01% | 30 |
|
|
2016
Q3 | $6.27M | Hold |
480,501
| – | – | 0.69% | 45 |
|
|
2016
Q2 | $3.29M | Buy |
480,501
+5,466
| +1% | +$37.4K | 0.47% | 53 |
|
|
2016
Q1 | $4.49M | Buy |
475,035
+118,435
| +33% | +$1.12M | 0.68% | 44 |
|
|
2015
Q4 | $3.59M | Hold |
356,600
| – | – | 0.43% | 53 |
|
|
2015
Q3 | $5.1M | Buy |
+356,600
| New | +$5.1M | 0.82% | 36 |
|